Advertisement
News
Advertisement

Natural Molecular Testing Corp. (NMTC) Names Karthikeshwar Kasirajan, M.D., as Chief Medical Officer

Wed, 02/29/2012 - 4:45am
The Associated Press

SEATTLE--(BUSINESS WIRE)--Feb 29, 2012-- Natural Molecular Testing Corp. (NMTC), a company providing groundbreaking clinical molecular testing and services in the medical genomics field, today announced that Karthikeshwar Kasirajan, M.D., has joined the company as Chief Medical Officer. Dr. Kasirajan will oversee the company's efforts to develop adverse drug interaction tools and disease registries, and expand NMTC's outreach to physicians and clinical partners.

NMTC, a privately-owned company, provides accurate and high-speed genetic testing to identify a patient's specific phenotypes. The test results offer physicians guidance in prescribing and dosing medication for more safe and effective treatment.

"Clinical molecular testing is playing an increasingly important role in better serving patients, and NMTC's cutting-edge laboratory provides physicians with important genetics data," said Dr. Kasirajan.

"I'm excited to support the company's focus on optimizing patient outcomes, cost-efficiencies for physicians, and lowering health-care costs through the use of genetic testing." NMTC Chief Executive Officer Beau R. Fessenden said Dr. Kasirajan's addition to the company's executive team accelerates several NMTC's initiatives.

"Physicians' knowledge of genomics varies widely and new advances are constant," said Fessenden. "Dr. Kasirajan brings a doctor's perspective to the real-world need for improved diagnostics by identifying patients' specific phenotypes." For the past decade Dr. Kasirajan has been widely published and active as a presenter and lecturer. He has held key professional positions with memberships in numerous medical societies. Dr. Kasirajan was most recently Director of Clinical Research and Endovascular Therapy at East Bay Cardiovascular & Thoracic Associates in Concord, CA. Prior to that he was Associate Professor of Surgery and Director of Clinical Research at Emory University Hospital and VAMC (Division of Vascular Surgery) in Atlanta, GA.

Dr. Kasirajan completed his residency at Western Reserve Care System in Youngstown, OH and received his M.B.B.S. (Bachelor of Medicine and Bachelor of Surgery) from Madras Medical College & Government Hospital in Madras, India.

About Natural Molecular Testing Corp. (NMTC) Natural Molecular Testing Corporation (NMTC) is a privately-owned, high-complexity molecular testing facility. NMTC provides genetic testing services and resources for our clinical partners to assist them in better caring for their patients by advancing patient care through the latest breakthroughs in genomic technology.

For more information about Natural Molecular Testing Corp., visit www.naturalmolecular.com.

CONTACT: Natural Molecular Testing Corporation Ken Wallace, 1-888-442-8881 Director of Business Development kenwallace@naturalmolecular.com or The Bartlett Group Public Relations Barry Bartlett, 206-335-4694 barry@bartlettgrouppr.com KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS PHARMACEUTICAL SOURCE: Natural Molecular Testing Corporation Copyright Business Wire 2012 PUB: 02/29/2012 09:02 AM/DISC: 02/29/2012 09:02 AM http://www.businesswire.com/news/home/20120229005463/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading